+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Angioedema Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767667
  • Report
  • April 2019
  • Region: Global
  • 109 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • CSL Ltd
  • Pharming Group NV
  • Quotient Sciences Ltd
  • Sanofi
  • Shire Plc
  • UCB SA
  • MORE
The global clinical trial report- “2019 Angioedema Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Angioedema. It presents in-depth analysis of Angioedema clinical trials across markets and companies. The research work is for providing complete understanding into trends in Angioedema.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Angioedema clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Angioedema

The research work is prepared through extensive and continuous research on Angioedema trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Angioedema patients are identified
  • The report includes panorama of Angioedema clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Angioedema clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • CSL Ltd
  • Pharming Group NV
  • Quotient Sciences Ltd
  • Sanofi
  • Shire Plc
  • UCB SA
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Angioedema Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Angioedema Clinical Trials by Region
2.2.2 Average Enrollment of Angioedema Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Angioedema Treatment, 2019

3. Region wise Angioedema Clinical Trials
3.1 Asia Pacific Angioedema Clinical Trials by Country
3.2 Europe Angioedema Clinical Trials by Country
3.3 North America Angioedema Clinical Trials by Country
3.4 Middle East and Africa Angioedema Clinical Trials by Country
3.5 South and Central America Angioedema Clinical Trials by Country

4. Angioedema Clinical Trial Trends
4.1 Start Year wise Angioedema Clinical Trials
4.2 Phase wise Angioedema Clinical Trials
4.3 Trial Status wise Angioedema Clinical Trials
4.4 Trial Type wise Angioedema Clinical Trials

5. Angioedema Average Enrollment Trends
5.1 Average Enrollment in Angioedema Trials by Year
5.2 Average Enrollment in Angioedema Trials by Phase
5.3 Average Enrollment in Angioedema Trials by Status
5.4 Average Enrollment in Angioedema Trials by Type of Trial

6. Companies Participating in Angioedema Clinical Trials
6.1 Angioedema Trials by Sponsor Type
6.2 Angioedema Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Angioedema Trials- Phase 1
7.2 Angioedema Trials- Phase 2
7.3 Angioedema Trials- Phase 3
7.4 Angioedema Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Angioedema Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Angioedema Clinical Trials and Enrolment
Figure 5: Europe - Country wise Angioedema Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Angioedema Clinical Trials and Enrolment
Figure 7: North America - Country wise Angioedema Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Angioedema Clinical Trials and Enrolment
Figure 9: Angioedema Clinical Trials by Phase
Figure 10: Angioedema Clinical Trials by Trial Status
Figure 11: Angioedema Clinical Trials by Type
Figure 12: Angioedema Clinical Trials by Sponsor Type
Figure 13: Angioedema Clinical Trials by Leading Sponsors
Figure 14: Angioedema Average Enrollment by Phase
Figure 15: Angioedema Average Enrollment by Trial Status
Figure 16: Angioedema Average Enrollment by Type
Figure 17: Angioedema- Average Enrolment by Type of Sponsors
Figure 18: Angioedema- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Angioedema Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Angioedema Clinical Trials and Enrolment
Table 5: Europe - Country wise Angioedema Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Angioedema Clinical Trials and Enrolment
Table 7: North America - Country wise Angioedema Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Angioedema Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Angioedema Average Enrollment by Phase
Table 15: Angioedema Average Enrollment by Trial Status
Table 16: Angioedema Average Enrollment by Type
Table 17: Angioedema- Average Enrolment by Type of Sponsors
Table 18: Angioedema- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Advanced Medical Services GmbH
  • Atlantic Research Group Inc
  • BioCryst Pharmaceuticals Inc
  • CSL Ltd
  • Kalvista Pharmaceuticals Inc
  • Pharming Group NV
  • Quotient Sciences Ltd
  • Sanofi
  • Shire Plc
  • UCB SA
Note: Product cover images may vary from those shown
Adroll
adroll